Therapy with antimicrobial drugs, such as clindamycin, that perturb the intestinal flora but fail
to inhibit growth of other microorganisms can permit the proliferation of Clostridium difficile …

Purpose. Clostridium difficile is an anaerobic spore-forming pathogen that causes a serious
toxin-mediated enteric disease in humans. Therapeutic agents that are capable of reducing …

Although antibiotics are generally effective in achieving symptomatic recovery from
Clostridium difficile infection, the disease frequently relapses, partly because antibiotics not …

Clostridium difficile infection (CDI) remains one of the greatest concerns in current
worldwide medical practice. Its incidence, severity and patient susceptibility range have …

Clostridioides difficile infection is a global health threat and remains the primary cause of
hospital-acquired infections worldwide. The burgeoning incidence and severity of infections …

Clostridium difficile is an anaerobic, Gram-positive pathogen that causes C. difficile infection,
which results in significant morbidity and mortality. The incidence of C. difficile infection in …

Probiotic bacteria are proposed for prevention of Clostridium difficile associated diarrhea.
The aim of this in vitro study was to evaluate the influence of five Lactobacillus plantarum …

The aim of the study was to investigate the influence of some commercial probiotics on the
growth of Clostridium difficile using isothermal microcalorimetry, a technique which can …

Importance of the field: Clostridium difficile is the most important definable cause of
healthcare acquired diarrhea. The increasing incidence and mortality associated with this …

Many of these new antibiotics display almost ideal properties for antibiotics directed against
CDI. Despite these properties, not all clinical development of these compounds has been …